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Voluntary breath-holdPurpose: To determine whether voluntary deep-inspiratory breath-hold (v_DIBH) and deep-inspiratory
breath-hold with the active breathing coordinator™ (ABC_DIBH) in patients undergoing left breast radio-
therapy are comparable in terms of normal-tissue sparing, positional reproducibility and feasibility of
delivery.
Methods: Following surgery for early breast cancer, patients underwent planning-CT scans in v_DIBH and
ABC_DIBH. Patients were randomised to receive one technique for fractions 1–7 and the second tech-
nique for fractions 8–15 (40 Gy/15 fractions total). Daily electronic portal imaging (EPI) was performed
and matched to digitally-reconstructed radiographs. Cone-beam CT (CBCT) images were acquired for
6/15 fractions and matched to planning-CT data. Population systematic (R) and random errors (r) were
estimated. Heart, left-anterior-descending coronary artery, and lung doses were calculated. Patient com-
fort, radiographer satisfaction and scanning/treatment times were recorded. Within-patient comparisons
between the two techniques used the paired t-test or Wilcoxon signed-rank test.
Results: Twenty-three patients were recruited. All completed treatment with both techniques. EPI-
derived R were 61.8 mm (v_DIBH) and 62.0 mm (ABC_DIBH) and r 62.5 mm (v_DIBH) and 62.2 mm
(ABC_DIBH) (all p non-signiﬁcant). CBCT-derived R were 63.9 mm (v_DIBH) and 64.9 mm (ABC_DIBH)
and r 6 4.1 mm (v_DIBH) and 6 3.8 mm (ABC_DIBH). There was no signiﬁcant difference between tech-
niques in terms of normal-tissue doses (all p non-signiﬁcant). Patients and radiographers preferred
v_DIBH (p = 0.007, p = 0.03, respectively). Scanning/treatment setup times were shorter for v_DIBH
(p = 0.02, p = 0.04, respectively).
Conclusions: v_DIBH and ABC_DIBH are comparable in terms of positional reproducibility and normal tis-
sue sparing. v_DIBH is preferred by patients and radiographers, takes less time to deliver, and is cheaper
than ABC_DIBH.
 2013 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 108 (2013) 242–247Breast cancer is the most common cancer in women, with a cur-
rent estimated worldwide incidence of 1.38 million [1]. With im-
proved treatments, the number of breast cancer (BC) survivors is
increasing, and in the UK alone is expected to treble to 1.7 million
by 2040 [2]. This surge in survivor numbers makes the late effects
of BC treatment, including those related to radiotherapy, of
increasing concern to patients and healthcare providers alike.
Breast radiotherapy reduces the risk of recurrence and improves
survival after surgical excision of early BC [3]. However, the bene-
ﬁts derived from breast radiotherapy are compromised by an in-
crease in non-BC deaths, the majority of which are cardiovascular
in origin [4]. Although it is not yet clear which cardiac structure(s)is most important in the pathogenesis of radiation related heart
disease (RRHD), the anatomical position of the left anterior
descending artery (LAD) makes it particularly susceptible to high
doses of radiation. There is nowmounting evidence that irradiation
of the LAD is a key factor in the development of RRHD [5–7].
Irradiation of other tissues, including lung and chest wall, also con-
tributes to late morbidity and mortality from breast radiotherapy
[4,8–10].
The current priority in breast radiotherapy is to develop and
validate techniques which enable clinicians to maintain coverage
of target tissues (breast/chest wall) whilst reducing radiation to
adjacent organs-at-risk (OAR), especially the heart and LAD.
Breath-holding techniques, in which the heart is pushed down
and away from the radiotherapy ﬁeld, are a solution to this prob-
lem. Compared to free-breathing radiotherapy, deep-inspiratory
breath-hold with the active breathing coordinator™ (ABC_DIBH)
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irradiated [11–13], whilst voluntary deep-inspiratory breath-hold
(v_DIBH) using the Varian RPM system has been shown to signiﬁ-
cantly reduce median heart and LAD volumes receiving >50% of the
prescription dose [14–16]. Such dosimetric savings are projected to
equate to a 10-fold reduction in cardiac deaths [16]. Nonetheless,
despite convincing evidence that DIBH reduces the dose delivered
to cardiac tissues, it was used in only 19% of EORTC centres 3 years
ago [17] and just 4% of UK centres in 2012 [Royal College of Radi-
ologists audit]. ABC_DIBH has been shown to be reproducible [18]
but is expensive to implement due to costs of equipment including
daily disposable mouthpieces. v_DIBH, in particular the technique
described in this study, would be a low-cost alternative but data on
its reproducibility are lacking. This randomised crossover study
was designed to answer whether or not the treatment of breast
radiotherapy patients in v_DIBH is at least as good as ABC_DIBH
in terms of positional reproducibility, normal tissue sparing and
feasibility of delivery.
Methods and materials
This study was approved by the Royal Marsden Committee for
Clinical Research and the Research Ethics Committee (ISRCTN
53485935). All women underwent left breast conserving surgery
or mastectomy for early stage invasive ductal or lobular carcinoma
(pT1-3b N0-1 M0) and were recommended adjuvant radiotherapy
to the whole breast or chest wall without nodal irradiation (+/ tu-
mour bed boost). Women with left breast cancer requiring radio-
therapy to the breast or chest wall alone were approached. All
patients were treated at the Royal Marsden Hospital, Sutton, UK.
Randomisation was arranged via telephone at the Clinical Trials
and Statistics Unit at the Institute of Cancer Research (ICR-CTSU),
Sutton, UK, where patient details were recorded and order of
breath-holding techniques was allocated. Randomisation was not
blinded. Computer-generated random permuted blocks of size 4
were used for allocation, with no stratiﬁcation.v_DIBH technique
The v_DIBH technique used in this study required no additional
equipment. Patients were asked to breathe in and out twice before
being asked to take a deep breath and hold. Breath-hold consis-
tency was checked at CT and treatment by the distance moved
by the laser from the anterior and lateral tattoos in breath-hold.
All breath-hold techniques require a method of monitoring intra-
fraction breath-hold reproducibility. In this study the borders of
the light ﬁeld were marked with ink with the patient in breath-
hold. Treatment room cameras were zoomed so that the pen marks
and light ﬁeld were visible on the control room monitors. Visualis-
ing these enabled radiographers to check breath-hold consistency
prior to and during treatment. A more detailed account of the
v_DIBH technique is given in the supplementary material.Patient positioning and image acquisition
Training was given to patients for both techniques immediately
prior to scanning. ABC_DIBH training followed the method de-
scribed by Remouchamps et al. [18] and for v_DIBH is described
in the supplementary material. Both CT scans were performed in
one CT-planning session and patients remained on the CT couch
between scans. All patients were scanned on a supine breast board,
with arms extended above the head in supports (Med-Tec, Iowa,
USA). Markers were placed bilaterally 1–2 cm posterior to the
mid-axillary line and aligned axially with a midline marker using
lateral lasers. CT data (Philips Medical Systems, UK) were acquired
without contrast in both ABC_DIBH and v_DIBH using 3 mm slicesfrom C6 to below the diaphragm. The time taken to complete each
planning session was recorded, from the time the patients
mounted the CT couch to the time at which they dismounted the
couch. After both scans were completed patients were asked to
complete validated comfort and acceptability questionnaires and
radiographers were asked to complete radiographer satisfaction
questionnaires [19].Target and organ-at-risk delineation
Target and OARs were delineated on both CT scans. The whole
breast clinical target volume (WCBTV) encompassed the breast tis-
sue visualised on CT (limited by pectoral fascia and 5 mm from
skin). The tumour bed was deﬁned using tumour bed clips (in-
serted at surgery), and included any associated seroma or distor-
tion of breast architecture. A uniform margin of 15 mm was
added (limited by WBCTV) to form the partial breast CTV (PBCTV).
For mastectomy patients, the chest wall CTV (CWCTV) was deﬁned
using anatomical landmarks (inferior border of clavicle (superior),
1 cm below inframammary fold (inferior), midline (medial) and
anterior border of serratus anterior (lateral)), taking into account
the position of the contralateral breast tissue and limited by pec-
toral fascia and 5 mm from skin. The heart was outlined in accor-
dance with the UK National Cancer Research Institute Intensity
Modulated and Partial Organ RadioTherapy (IMPORT) study crite-
ria [20]. The LAD was outlined according to the method described
by Taylor et al. [21,22]. The lungs were outlined by adapting a pre-
installed lung template and edited to exclude major airways.Radiotherapy planning
Tangential ﬁelds were applied to encompass WBCTV/CWCTV.
The depth of lung tissue included in tangential ﬁelds was
62.5 cm. Philips Pinnacle 9.2 (Philips Medical Systems, Palo Alto,
USA) and the collapsed-cone algorithm (0.25  0.25  0.25 cm res-
olution) were used to produce plans such that P90% of the
WBCTV/CWCTV and P95% of the PBCTV were covered by the
95% isodose [23]. Where required, MLC leaves were used to shield
cardiac tissue whilst maintaining target tissue constraints. Seg-
ments (ﬁeld-in-ﬁeld technique) were used, where necessary, to im-
prove dose homogeneity and all plans fulﬁlled ICRU 62 criteria
(dose variation 6 +7% and 5%, hotspots 6 107%) [24]. Patients
were prescribed 40 Gy in 15 fractions over 3 weeks using 6 or 10
MV photons.
Tabular DVH data (dose (Gy) per voxel) were used to derive the
NTDmean (a biologically weighted mean of total dose to tissue nor-
malised to 2 Gy fractions using a standard linear quadratic model
[25], a/b = 3 Gy) for heart, LAD, ipsilateral and whole lungs. In addi-
tion, the maximum dose received by the LAD (LADmax) was
estimated.Radiotherapy delivery
Patients were randomised to receive one treatment technique
for fractions 1–7 and the second technique for fractions 8–15. Pa-
tient setup is described in the supplementary material. Real-time
electronic portal images (EPI) were acquired daily and matched
on-line to DRRs on fractions 1–3 and 8–10 using iView software
(Elekta, Crawley, UK). Shifts were applied if errors were >5 mm
in the (u,v)-plane on at least two consecutive days. For study pur-
poses setup errors were measured off-line for every fraction. The
left posterior oblique beam (LPO) was treated ﬁrst and the right
anterior oblique beam (RAO) treated second.
On-board kV-CT (CBCT) images of the chest were acquired
immediately after setup on fractions 1, 4, 7, 8, 11 and 14 using
the Elekta Synergy X-ray Volume Imaging System (Elekta, Crawley,
244 The UK HeartSpare StudyUK). CBCT procedures have been described previously [26]. CBCT
data were acquired for study purposes only and were not used to
make isocentre shifts. For technical reasons it was not possible to
interrupt CBCTs, meaning that patients could only be in breath-
hold for about two-thirds of the time taken to complete the CBCT.
The CBCT volume was manually registered to the reference plan-
ning-CT, and both chest wall and clip-based matches were per-
formed. For chest wall matches, a best-ﬁt match was made for
the area of chest wall directly posterior to the target tissue. The
correction reference point was set to the isocentre.
On average, four to six breath-holds were required per treat-
ment, with two extra for CBCT imaging.
Times at which patients mounted the couch, the radiotherapy
beam was switched on and off and at which patients dismounted
the couch, were recorded for every fraction. Patients and radiogra-
phers were asked to complete questionnaires on fractions 1, 7, 8
and 15.Statistical methods
A sample size of 23 patients was estimated to provide 95%
power in order to rule out an excess of 2 mm inmean displacement
(primary outcome) for v_DIBH versus ABC_DIBH, assuming a sig-
niﬁcance level of 0.05 (1-sided as testing for non-inferiority). EPI
displacements were analysed for each beam in the (u,v)-plane for
every patient (v-direction parallel to craniocaudal axis and u-direc-
tion perpendicular to this) [27]. Mean displacements and standard
deviations were compared for ABC_DIBH and v_DIBH treatments
for each patient. Using the method described by van Herk [28],
population mean displacement (MD), systematic (R) and random
(r) errors were estimated. CBCT registration results were analysed
in 3-dimensions for each patient and for both chest wall and clip-
based matches; population MD, R and r were calculated. Paired t-
tests were used to compare the parameters listed above (popula-
tion MD, R and r), normal tissue doses and timing data (CT and
treatment session times) between ABC_DIBH and v_DIBH, using
each patient as their own control. Data normality was conﬁrmed
using Q–Q plots and Kolmogorov–Smirnov tests (all p non-signiﬁ-
cant). Patient comfort and acceptability questionnaires were sum-
marised as patient comfort scores ranging from 0 (least
comfortable) to 9 (most comfortable). Radiographer satisfaction
questionnaires were summarised as radiographer satisfaction
scores ranging from 0 (most satisfactory) to 9 (least satisfactory).
Scores were calculated for each technique and at each timepoint
(CT, ﬁrst and last fractions). In order to eliminate any time effect,
the difference in questionnaire scores between the two techniques
at each timepoint was calculated for each patient. Single sample
Wilcoxon signed-rank tests were then used to test whether the
median of the differences was signiﬁcantly different from zero.
Statistical analyses were performed using SPSS Statistics Ver-
sion 19 (IBM, Portsmouth, UK).Results
Twenty-three patients were randomised between February and
August 2012. The study ended when the ﬁnal patient completed
their radiotherapy course, and there was no long-term trial-related
follow-up. All patients completed treatment with both techniques.
The median age of patients recruited was 61 years (range 36–82).
Nineteen patients (83%) underwent BCS and four (17%) underwent
mastectomy. Table S1 (supplementary material) shows mean tar-
get and OAR volumes for both techniques. Mean WBCTV was sim-
ilar for both techniques: 677 cm3 (ABC_DIBH) vs 676 cm3 (v_DIBH),
as was mean target tissue coverage. There was no signiﬁcant differ-
ence in lung volumes between the two techniques. However, heartvolumes were signiﬁcantly smaller with v_DIBH: 577 cm3 vs
544 cm3 (p < 0.001).
Table 1 shows population MD, R and r estimated using EPI.
There was no signiﬁcant difference between the two techniques
in MD, R or r.
Table 2 shows population MD, R and r for CBCT chest wall and
clip-based matches. Twenty-two patients underwent CBCTs and
clip-based matches were possible in 18 (4 patients underwent
mastectomy). There was no signiﬁcant difference between the
two techniques in R or r for either chest wall or clip-based
matches. MD was less with v_DIBH in the anterior–posterior (AP)
direction. Errors were generally greater for chest wall matches
than for clip-based matches.
There was no signiﬁcant difference between mean normal tis-
sue doses (Gy) for ABC_DIBH and v_DIBH (standard deviation in
brackets): heart NTDmean 0.6 (0.2) vs 0.6 (0.1) (p = 0.41), LAD
NTDmean 3.8 (2.9) vs 3.5 (2.3) (p = 0.18), LADmax 32.6 (11.5) vs
30.6 (12.4) (p = 0.18), ipsilateral lung NTDmean 4.2 (0.7) vs 4.2
(0.7) (p = 0.53), whole lung NTDmean 2.0 (0.3) vs 2.0 (0.3)
(p = 0.22). Fig. 1 demonstrates the heart-sparing effect of DIBH.
The number of patients in whom the median of the differences
in patient comfort scores at each timepoint (CT, ﬁrst and last frac-
tions) was <0 (1), 0 (9) or >0 (12), p = 0.007 (i.e. patients found
v_DIBH more comfortable) and for radiographer satisfaction scores
<0 (9), 0 (11) or >0 (3), p = 0.03 (i.e. radiographers found v_DIBH
more satisfactory).
Mean planning-CT session times (minutes) were 27 (ABC_DIBH)
and 24 (v_DIBH) (p = 0.02). Mean treatment setup times were 11
(ABC_DIBH) and 9 (v_DIBH) (p = 0.04), mean treatment times (ﬁrst
beam onto last beam off) were 7 min for both techniques (p = 0.08),
mean dismount time 2 min for both (p = 0.97). Mean total treat-
ment time per session was 19 min for both techniques (p = 0.62).Discussion
This randomised crossover study compared ABC_DIBH and
v_DIBH in terms of setup reproducibility, normal tissue sparing
and feasibility of delivery. Our results demonstrate that the two
techniques are similar in terms of these parameters. Consistent
with other published data, both techniques were well tolerated
[15,18]. Baseline data (Table S1, supplementary material) suggest
that target volume outlining was consistent. Lung volumes were
similar for both techniques, minimising any effect on calculated
cardiac doses. Heart volumes were signiﬁcantly smaller with
v_DIBH, suggesting a different physiological response between a
machine-initiated breath-hold (ABC_DIBH) and a voluntarily-initi-
ated breath-hold (v_DIBH).
Treatment setup errors were consistent with other studies of
DIBH which have used EPI for veriﬁcation [18,29], but smaller than
many free-breathing studies [30], suggesting that DIBH is at least
as reproducible as standard free-breathing breast radiotherapy.
In this study, errors were greatest in the u-direction, which is sub-
ject to the most change with variations in depth of DIBH or breath-
ing pattern (e.g. chest vs abdominal breathing).
Population MD, R and r derived from CBCT data were greater
than errors derived from EPI. EPI is known to underestimate setup
errors in breast cancer patients due to differences in visibility of
anatomical landmarks between the two imaging techniques, time
taken to acquire images and the fact that CBCT provides 3D ana-
tomical information [31]. The inability to interrupt CBCT acquisi-
tion resulted in some image blurring and compromised
matching. Chest wall deformation during respiration meant that
chest wall matches were subject to greater errors than clip-based
matches. In view of this, it is likely that CBCT-derived setup errors
in this study are an overestimate of the true setup errors associated
Table 1
Population mean displacement (MD), systematic (R) and random (r) setup errors for ABC_DIBH and v_DIBH techniques measured by electronic portal imaging (EPI) for each
beam and in the (u,v)-plane (mm).
Right anterior oblique beam (RAO) Left posterior oblique beam (LPO)
ABC_DIBH v_DIBH p ABC_DIBH v_DIBH p
u-direction MD 0.5 0.2 0.52 0.5 0.1 0.49
R 1.9 1.8 2.0 1.5
r 2.2 2.1 0.74 2.4 2.5 0.24
v-direction MD 0.7 0.5 0.63 0.9 0.8 0.79
R 2.0 1.7 1.9 1.5
r 2.0 1.7 0.46 2.0 2.0 0.83
Total number of EPIs: 665.
Table 2
Population mean displacement (MD), systematic (R) and random (r) errors in 3-dimensions for chest wall and clip-based cone-beam CT versus planning CT matches for
ABC_DIBH and v_DIBH techniques (mm).
Chest wall match Clip-based match
ABC_DIBH v_DIBH p ABC_DIBH v_DIBH p
Right–left (R–L) MD 0.3 0.5 0.78 0.4 0.4 0.93
R 4.4 2.5 3.2 2.4
r 3.8 2.4 0.07 2.3 2.3 0.99
Superior–inferior (S–I) MD 2.3 3.4 0.32 0.1 1.7 0.10
R 4.9 3.9 2.9 3.6
r 3.3 4.1 0.62 3.4 2.7 0.42
Anterior–posterior (A–P) MD 1.7 0.3 0.03 1.8 0.6 0.01
R 3.3 2.8 2.7 3.0
r 2.6 2.7 0.76 3.5 2.7 0.53
Total number of CBCTs: 126.
Fig. 1. Axial CT slices of one patient taken during free breathing, v_DIBH and ABC_DIBH. Heart, left anterior descending coronary artery (LAD) and LAD with 1 cmmargin have
been outlined. Key: magenta – heart, orange – LAD, dark green – LAD plus 1 cm margin.
F.R. Bartlett et al. / Radiotherapy and Oncology 108 (2013) 242–247 245with these techniques. Clip-based match errors were better than
DIBH setup data reported by another centre [29]; in relation to
free-breathing data, r were similar but R greater than previously
reported [32]. The difference in MD in the AP direction suggests
imprecision of the ABC equipment and/or procedure. Possible
explanations for this include inaccurate spirometry or balloon
valve cut-off and the inability of the ABC device to control breath-
ing pattern or chest wall shape.
Our results suggest that there is no signiﬁcant difference be-
tween ABC_DIBH and v_DIBH in terms of normal tissue sparing.
Cardiac doses reported in this study were lower than in other pub-
lished data [29,33–36], although comparison is not straightforward
due to differences in target volumes and LAD margins. Ipsilateral
lung doses were consistent with other published works [29,34],
although whole lung doses are not widely reported.
By freeing patients of equipment, v_DIBH was seen as more
comfortable than ABC_DIBH. Patients found the mouthpiece and
nose-clip used in ABC_DIBH claustrophobic. One patient with den-
tures found the ABC mouthpiece difﬁcult to grip. Given thatv_DIBH was a new technique to our department (unlike ABC_DIBH)
it was encouraging that radiographers found v_DIBHmore satisfac-
tory than ABC_DIBH.
The timing data demonstrate small but signiﬁcant advantages
with v_DIBH at planning-CT and treatment setup. The difference
at CT can be accounted for by the need to set an inspiratory thresh-
old for ABC_DIBH at this session (not required for v_DIBH), and at
treatment setup by the fact that a radiographer must leave the
room to operate the ABC device. Treatment times for both tech-
niques are likely to be shorter than suggested as CBCTs are not part
of standard treatment.
ABC_DIBH is expensive due to capital investment in the device
itself and the ongoing costs of single-use mouthpieces. The v_DIBH
technique described here is a less costly alternative as no specia-
lised equipment is required. v_DIBH currently takes longer to deli-
ver than our centre’s free-breathing technique although treatment
times are expected to fall with increasing experience. This is the
subject of an ongoing service evaluation within our institution.
Whilst the capital costs associated with ABC_DIBH are a major
246 The UK HeartSpare Studyfactor in preventing its widespread uptake across the UK National
Health Service (NHS), the results presented here should reassure
centres with ABC about the reproducibility and normal tissue spar-
ing of ABC_DIBH in left breast radiotherapy. Otherwise, v_DIBH ap-
pears to be an effective, reproducible, comfortable and less costly
alternative. The feasibility of rolling out v_DIBH to other UK cen-
tres will now be assessed in the context of the UK NCRI FAST-For-
ward trial (HeartSpare II), with the ultimate aim of increasing
availability of heart-sparing breast radiotherapy in the UK. Further
work is needed to evaluate the role of v_DIBH in breast radiother-
apy for nodal irradiation and partial breast treatment.
Conclusion
Our data suggest that ABC_DIBH and v_DIBH are comparable in
terms of positional reproducibility and normal tissue sparing. Pa-
tients ﬁnd v_DIBH more comfortable than ABC_DIBH, and radiog-
raphers ﬁnd v_DIBH more satisfactory. v_DIBH offers a time
advantage at planning-CT sessions and treatment setup, and is
cheaper as no specialised equipment is required.
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